10 completed, 3 terminated, 2 unknown, 2 withdrawn. 17 Phase 2, 4 Phase 3, 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 17 | Completed 10, Terminated 3, Unknown 2, Withdrawn 2 |
| Phase 3 | 4 | Completed 3, Unknown 1 |
| Phase 1 | 3 | Completed 1, Terminated 1, Withdrawn 1 |
Follow nabilone: new trials by email Literature Review of nabilone trials Research Report on nabilone
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Nabilone for Agitation in Frontotemporal Dementia Nabilone, Placebo - Frontotemporal Dementia, Frontotemporal Dementia, Behavioral Variant | Phase 2 | Terminated | Simon Ducharme, MD | 3 | 2023-03-07 | 2026-07-28 |
| Effect of PP-01 on Cannabis Withdrawal Syndrome PP-01 High Dose, PP-01 Low Dose, Placebo - Cannabis Withdrawal | Phase 2 | Completed | PleoPharma, Inc. | 234 | 2022-10-27 | 2024-08-16 |
| Multimodal Assessment of Cannabinoid Target Engagement in Adults With Obsessive-Compulsive Disorder Nabilone, Placebo - Obsessive-Compulsive Disorder | Phase 1 / Phase 2 | Withdrawn | New York State Psychiatric Institute | 2022-03-01 | 2024-05-21 | |
| A Pilot Trial of Nabilone for the Treatment of Obesity Placebo, Nabilone - Obesity | Phase 2 | Terminated | Centre for Addiction and Mental Health | 18 | 2021-09-17 | 2026-04-09 |
| Adjunctive CB1 Agonist Nabilone in Inpatients With Active Suicidal Ideation Nabilone, Placebo - Suicidal Ideation | Phase 2 | Withdrawn | The University of Texas Health Science Center, Houston | 2021-04-01 | 2021-09-22 | |
| Nabilone for Non-motor Symptoms in Parkinson's Disease Nabilone 0.25 mg, Placebo - Parkinson Disease | Phase 2 | Completed | Medical University Innsbruck | 48 | 2017-10-03 | 2021-03-02 |
| Cannabinoid Medication for Adults With OCD Nabilone, Exposure and Response Prevention Therapy - Obsessive-Compulsive Disorder | Phase 1 / Phase 2 | Completed | New York State Psychiatric Institute | 16 | 2016-09-01 | 2020-08-06 |
| Nabilone in Cannabis Users With PTSD Nabilone, Cannabis, Propranolol - Cannabis, Post Traumatic Stress Disorder | Phase 1 / Phase 2 | Terminated | New York State Psychiatric Institute | 4 | 2015-10-01 | 2022-07-15 |
| Safety and Efficacy of Nabilone in Alzheimer's Disease Nabilone, Placebo - Alzheimer Disease, Agitation | Phase 2 / Phase 3 | Completed | Sunnybrook Health Sciences Centre | 38 | 2015-01-01 | 2020-06-25 |
| Nabilone Effect on the Attenuation of Anorexia, Nutritional Status and Quality of Life in Lung Cancer Patients Nabilone, Placebo - Non-Small Cell Lung Cancer, Anorexia | Phase 2 / Phase 3 | Unknown | Instituto Nacional de Cancerologia de Mexico | 78 | 2014-12-01 | 2016-08-31 |
| Study of Prevention of Postoperative Nausea and Vomiting Using Cesamet Nabilone, Placebo - Postoperative Nausea and Vomiting | Phase 2 | Completed | Unity Health Toronto | 331 | 2014-04-01 | 2015-12-03 |
| Effect of Cannabinoids on Spasticity and Neuropathic Pain in Spinal Cord Injured Persons nabilone 0.5 mg, placebo - Muscle Spasticity as a Result of Spinal Cord Injury | Phase 2 | Completed | University of Manitoba | 12 | 2012-06-01 | 2015-02-25 |
| Nabilone for Cannabis Dependence: A Pilot Study Nabilone, Placebo - Cannabis Dependence, Marijuana Dependence | Phase 2 / Phase 3 | Completed | Mclean Hospital | 84 | 2010-06-01 | 2018-06-01 |
| Nabilone & Marijuana Addiction Cesemat - Marijuana Smoking | Phase 2 / Phase 3 | Completed | University of British Columbia | 35 | 2009-06-01 | 2011-02-17 |
| Nabilone for the Treatment of Phantom Limb Pain Nabilone - Phantom Limb Pain, Neuropathic Pain | Phase 2 | Completed | University of Manitoba | 50 | 2009-01-01 | 2011-04-29 |
| A Trial Assessing the Effect of Nabilone on Pain and Quality of Life in Patients With Fibromyalgia Nabilone - Fibromyalgia | Phase 2 | Completed | Winnipeg Regional Health Authority | 40 | 2006-04-01 | 2011-08-25 |
| Use of the Cannabinoid Nabilone for the Promotion of Sleep in Chronic, Non-Malignant Pain Patients Nabilone - Pain, Insomnia | Phase 2 | Unknown | University Health Network, Toronto | 16 | 2005-12-01 | 2006-10-06 |
Pain (4) · Marijuana Abuse (3) · Obsessive-Compulsive Disorder (2) · Psychomotor Agitation (2) · Alzheimer Disease (1) · Anorexia (1) · Aphasia, Primary Progressive (1) · Cachexia (1) · Carcinoma, Non-Small-Cell Lung (1) · Dementia (1) · Fibromyalgia (1) · Frontotemporal Dementia (1) · Marijuana Smoking (1) · Muscle Spasticity (1) · Neuralgia (1)
New York State Psychiatric Institute (3) · University of Manitoba (2) · Centre for Addiction and Mental Health (1) · Instituto Nacional de Cancerologia de Mexico (1) · Mclean Hospital (1) · Medical University Innsbruck (1) · PleoPharma, Inc. (1) · Simon Ducharme, MD (1) · Sunnybrook Health Sciences Centre (1) · The University of Texas Health Science Center, Houston (1) · Unity Health Toronto (1) · University Health Network, Toronto (1) · University of British Columbia (1) · Winnipeg Regional Health Authority (1)
Canada (9) · United States (6) · Austria (1) · Mexico (1)
Aaron P Hong, MD, FRCPC (1) · Bernard Le Foll, MD, PhD (1) · Colin M. Shapiro, MBBCh, PhD (1) · Helen B Simpson, M.D., Ph.D. (1) · Jay Constantine, MD (1) · Karen D. Ethans, MD (1) · Kevin P Hill, MD, MHS (1) · Lena Galimova, MD (1) · Nathan Herrmann, MD (1) · Oscar Arrieta, MD M Sc (1) · Reilly Kayser, MD (1) · Rodrigo Machado-Vieira, MD, PhD, MSc (1) · Ryan Q Skrabek, MD, FRCPC (1) · Ryan Skrabek, MD (1)
PMID 11786587, PMID 12457271, PMID 15778874, PMID 15857739, PMID 16376734, PMID 16408219, PMID 1666930, PMID 16849753, PMID 17589370, PMID 18402303, PMID 21343383, PMID 28160217, PMID 29550881, PMID 30753761, PMID 31182351, PMID 31322567, PMID 31547752, PMID 32757413, PMID 34532852, PMID 35937495, PMID 3774823, PMID 40353878, PMID 8035251, PMID 8558188
K23MH125315 (1), K99DA029115 (1), U54DA037842 (1)